The current APLM market cap is 7.21M. The company's latest EPS is USD -156.5308 and P/E is -0.04.
Year End December 30 2023 | 2022 | 2023 |
---|---|---|
USD ($) | USD ($) | |
Total Revenue | 1.45M | 1.22M |
Operating Income | -233.6M | -53.62M |
Net Income | -240.81M | -172.6M |
Year End December 30 2023 | 2022 | 2023 |
---|---|---|
USD ($) | USD ($) | |
Total Assets | 76.48M | 55.39M |
Total Liabilities | 524.6M | 14.15M |
Total Equity | -448.12M | 41.23M |
Market Cap | 7.21M |
Price to Earnings Ratio | -0.04 |
Price to Sales Ratio | 5.93 |
Price to Cash Ratio | 0.22 |
Price to Book Ratio | 0.17 |
Dividend Yield | - |
Shares Outstanding | 1.1M |
Average Volume (1 week) | 3.23k |
Average Volume (1 Month) | 5.54k |
52 Week Change | -90.66% |
52 Week High | 80.50 |
52 Week Low | 6.20 |
Spread (Intraday) | 9.74 (61.07%) |
Company Name | Apollomics Inc |
Address |
989 e. hillsdale blvd foster city, california 94404 |
Website | https://www.apollomicsinc.com |
Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions